Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Emerson

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Endocrinology|April 1, 1986
A new class of propylthiouracil analogs: comparison of 5'-deiodinase inhibition and antithyroid activityT Nogimori, L E Braverman, A Taurog, et al.
Endocrinology|March 1, 1988
The effect of thyroid dysfunction and fasting on placenta inner ring deiodinase activity in the ratC H Emerson, G Bambini, S Alex, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1985
Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinomaR Rajatanavin, C Liberman, G D Lawrence, et al.
Endocrinology|September 1, 1993
Gene expression and serum thyroxine-binding globulin are regulated by adrenal status and corticosterone in the ratC H Emerson, C M Seiler, S Alex, et al.
Journal of Medicinal Chemistry|November 1, 1985
Synthesis of 6-anilino-2-thiouracils and their inhibition of human placenta iodothyronine deiodinaseT Nogimori, C H Emerson, L E Braverman, et al.
Endocrinology|June 1, 1996
Comparison of the effects of propylthiouracil and selenium deficiency on T3 production in the ratI E Veronikis, L E Braverman, S Alex, et al.
Neuroendocrinology|August 15, 1998
Arcuate nucleus ablation prevents fasting-induced suppression of ProTRH mRNA in the hypothalamic paraventricular nucleusG Legradi, C H Emerson, R S Ahima, et al.
Endocrinology|June 2, 1998
Vasopressin messenger ribonucleic acid regulation via the protein kinase A pathwayR L Emanuel, Y Iwasaki, Z K Arbiser, et al.
Acta Endocrinologica|February 1, 1989
TRH pharmacokinetics and nerve stimulation evoked prostatic fluid secretion during TRH infusion in the dogC Liberman, T Nogimori, C F Wu, et al.
Endocrinology|May 18, 2001
Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axisC Fekete, J Kelly, E Mihály, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Endocrinology|April 1, 1986
A new class of propylthiouracil analogs: comparison of 5'-deiodinase inhibition and antithyroid activityT Nogimori, L E Braverman, A Taurog, et al.
Endocrinology|March 1, 1988
The effect of thyroid dysfunction and fasting on placenta inner ring deiodinase activity in the ratC H Emerson, G Bambini, S Alex, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1985
Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinomaR Rajatanavin, C Liberman, G D Lawrence, et al.
Endocrinology|September 1, 1993
Gene expression and serum thyroxine-binding globulin are regulated by adrenal status and corticosterone in the ratC H Emerson, C M Seiler, S Alex, et al.
Journal of Medicinal Chemistry|November 1, 1985
Synthesis of 6-anilino-2-thiouracils and their inhibition of human placenta iodothyronine deiodinaseT Nogimori, C H Emerson, L E Braverman, et al.
Endocrinology|June 1, 1996
Comparison of the effects of propylthiouracil and selenium deficiency on T3 production in the ratI E Veronikis, L E Braverman, S Alex, et al.
Neuroendocrinology|August 15, 1998
Arcuate nucleus ablation prevents fasting-induced suppression of ProTRH mRNA in the hypothalamic paraventricular nucleusG Legradi, C H Emerson, R S Ahima, et al.
Endocrinology|June 2, 1998
Vasopressin messenger ribonucleic acid regulation via the protein kinase A pathwayR L Emanuel, Y Iwasaki, Z K Arbiser, et al.
Acta Endocrinologica|February 1, 1989
TRH pharmacokinetics and nerve stimulation evoked prostatic fluid secretion during TRH infusion in the dogC Liberman, T Nogimori, C F Wu, et al.
Endocrinology|May 18, 2001
Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axisC Fekete, J Kelly, E Mihály, et al.
Pageof 7